HealthTree Logo
search more_vert
person Sign In / Create Account
What Is Secondary Myelofibrosis?
Posted: Mar 28, 2024
What Is Secondary Myelofibrosis?  image

Myelofibrosis (MF) is a complex blood disorder characterized by an enlarged spleen, various blood cell abnormalities, and potential complications such as vascular issues and progression to a more aggressive phase. Diagnosing MF involves thorough assessments, including blood tests, bone marrow analysis, genetic evaluations, and understanding your medical history. At the American Society of Hematology (ASH) 2023, Passamonti and Mora provided an updated review of myelofibrosis and its secondary causes. 

Secondary myelofibrosis (SMF) encompasses a range of conditions where the bone marrow's ability to produce blood cells is restricted, leading to fibrosis. Due to its multiple causes, it occurs more commonly than primary myelofibrosis. 

What Causes Secondary Myelofibrosis?

Secondary Myelofibrosis is a result of previous damage to the bone marrow, for it to be considered secondary, there must be a health history of any of the following conditions: 

  • Key genetic mutations like JAK2V617F, CALR, and MPL 
  • Chronic kidney disease 
  • Long-term chemotherapy use, especially drugs that are poisonous to the blood cells
  • Hemolytic anemias
  • Abnormal growth of cells or tissues in the body(?)
  • Leukemia, multiple myeloma, or other blood cancers 
  • Cancer cells that have spread throughout the body
  • Inflammatory processes that have passed like; granulomas, osteomyelitis, autoimmune disorders, etc 
  • Conditions of the bone marrow, like scars from biopsies, dead tissue or radiation 
  • Bone diseases that affect bone replacement and formation

Myelofibrosis is caused when fibroblasts (cells that create scar tissue) grow in the bone marrow, interfering with the blood supply and replacing blood-forming cells with inactive fibrous tissue. So, anything that can cause fibrous tissue to form in the bone marrow can potentially induce secondary myelofibrosis. 

If you want to receive updated information on myelofibrosis, you can create an account at HealthTree Cure Hub to participate in webinars, events, and more! 


The author Jimena Vicencio

about the author
Jimena Vicencio

Jimena is an International Medical Graduate who is part of the HealthTree Patient Experience team. She loves learning new things led by her curiosity, playing with her pets, and exercising in her free time.

Get the latest thought leadership on Myelofibrosis delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myelofibrosis Newsletter" for Myelofibrosis news, life with Myelofibrosis stories, Myelofibrosis clinical trials, Myelofibrosis 101 articles and events with Myelofibrosis experts.

Thanks to our HealthTree Community for Myelofibrosis Sponsors:

Karyopharm Therapeutics

Follow Us

facebook instagram youtube